Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ATP synthase beta subunit is a principal component of the F1 catalytic core of the ATP synthase enzyme complex, which is embedded in the mitochondrial inner membrane. The ATP synthase operates as a rotary molecular motor: the beta subunit hosts the catalytic nucleotide binding sites where ADP and inorganic phosphate are converted to ATP using energy derived from a proton gradient across the membrane. Three beta and three alpha subunits form a hexameric ring structure in the F1 domain; the beta subunits alternate with alpha subunits, and together they enable the binding-exchange mechanism of ATP synthesis. Dysfunction or mutation in this subunit can impair cellular energy metabolism, contribute to mitochondrial diseases, and has been linked to pathologies such as cancer via mitochondrial bioenergetic reprogramming.
Inhibitors block proton flow or rotation, halting ATP production and mitochondrial energy generation Modulators may stabilize or destabilize the enzyme, affecting cellular energy status
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ATP synthase beta subunit (ATP5B).